PPD, Inc. and Lupus Therapeutics (LT), an affiliate of the Lupus Research Alliance have entered into a collaboration to expand and enhance lupus clinical research for PPD’s pharmaceutical and biotech customers.   Through the collaboration, PPD can provide enhanced protocol and trial optimization capabilities for its customers, leveraging LT’s scientific, operational and drug development expertise, as well as LT’s preferred investigators and Lupus Clinical Investigators Network (LuCIN) sites. I...